Community Oncology Services Market Estimated Growth Curve And Demand Analysis 2024-2033

Global community oncology services market size is expected to reach $89.48 Bn by 2028 at a rate of 10.4%, segmented as by type, small community oncology clinics, medium community oncology clinics, large community oncology clinics

Jul 8, 2024 - 14:59

Community Oncology Services Market Estimated Growth Curve And Demand Analysis 2024-2033

Overview and Scope

Community oncology includes a private physician who does not work for a hospital or a medical institution. It is used for community welfare purposes.

Sizing and Forecast

The community oncology services market size has grown rapidly in recent years. It will grow from $53.79 billion in 2023 to $60.31 billion in 2024 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to increased healthcare expenditure, rapid growth in elderly population, and health insurance reforms.

The community oncology services market size is expected to see rapid growth in the next few years. It will grow to $89.48 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increased healthcare expenditure, rapid growth in elderly population, and health insurance reforms. Major trends in the forecast period include focus on focus on providing telehealth services, increasing investments, partnerships and collaborations, developing individualized service plans, technological advancements, mergers and acquisitions.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/community-oncology-services-global-market-report

Segmentation & Regional Insights

The community oncology services market covered in this report is segmented –

1) By Type: Small Community Oncology Clinics, Medium Community Oncology Clinics, Large Community Oncology Clinics

2) By Cancer Type: Breast Cancer, Lung Cancer, Kidney Cancer, Ovarian Cancer, Prostate Cancer, Skin Cancer, Pancreatic Cancer, Blood Cancer, Colorectal Cancer, Other Cancer Types

3) By Therapy Type: Medical Oncology, Radiation Oncology, Surgical Oncology, Other Therapies

North America was the largest region in the oncology services market in 2023. Western Europe was the second largest region in the global oncology services market. The regions covered in the community oncology services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3369&type=smp

Major Driver Impacting Market Growth

The lower-cost care in community oncology centers is anticipated to boost the demand for the community oncology service market. The cancer care services are considered to be cost-effective in community oncology centers as compared to hospitals. According to the Community Oncology Alliance’s report published, the cost of cancer care per patient per month for various tumors in community-based clinics (CCs) was approximately $12,000 whereas the cost of cancer care in hospital-based oncology clinics (HCs) was about $20,000. Furthermore, the cost per patient per month for treatment of chemotherapy in a community setting was nearly $5,000 compared to around $8,500 in hospital-based clinics. Hence, the low cost of community oncology settings or community oncology centers are expected to drive the demand for the growth of the community oncology services market over the forecast years.

Key Industry Players

Major companies operating in the community oncology services market report are The US Oncology Network, OneOncology, Florida Cancer Specialists & Research Institute (FCS), The Oncology Institute, Community Care Physicians, P.C. (CCP), GenesisCare, CStone Pharma, CARsgen Therapeutics, JW Therapeutics, BeiGene, Nanjing Legend Pharmaceutical & Chemical Co., Ltd, Zai Labare, Taxane HealthCare Pvt Ltd, Getwell Oncology, Novartis Oncology, Celgene, Johnson & Johnson, Janssen Pharma, Pharmacyclics, Healthkind Labs Pvt Ltd, Arlak Biotech, SwisscheM Healthcare Pvt Ltd, Apikos Pharma, Kolaz Biotech, Quironsalud Proton Therapy Centre, The London Clinic England, Institut Gustave Roussy, Netherlands Cancer Institute, European Medical Center, Yauza Medical Center, Celon Pharma, Nebraska Cancer Specialists, Tufts Medical Center, Doctors Medical Center, Oncology Specialists SC, Baptist Cancer Center, Mayo Clinic, Cleveland Clinic, Fred Hutchinson Cancer Research Center, The University of Texas Southwestern Medical Center, Abramson Cancer Center, McKesson Corporation , TUTEUR Argentina, Takeda Pharmaceutical Company Limited, Pierre Fabre Group, Celnova Pharma , King Hussein Cancer Center (KHCC), Princess Noorah Oncology Center (PNOC), King Abdulaziz Medical City, King Faisal Specialist Hospital and Research Centre, King Fahd Specialist Hospital, Prince Sultan Medical Military City, King Saud Medical City, King Abdullah Medical City, Tawam Hospital , Icon Oncology, Eurolab Science Laboratuvar, Yemaachi Biotechnology, Regal Pharmaceuticals Limited, Ocean Road Cancer Institute

The community oncology services market report table of contents includes: